Summary
Clarivate Q2 Earnings Call Highlights
Clarivate NYSE: CLVT said during its earnings call that it expects organic recurring revenue and annualized contract value growth to improve in the second half of the year, citing renewal visibility, product momentum and a growing pipeline of AI-enabled offerings.
Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Clarivate (CLVT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates
Clarivate PLC (CLVT) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago.
Clarivate Plc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 38 | $129.84 | $73.72 | -$56.12 | -43.22% |
| NA Nizar Araji National Bank Of Canada /FI/ | 1.35M | $8.77M | $2.45M | -$6.32M | -72.08% |
| MV Michele Vadala TIMUCUAN ASSET MANAGEMENT Inc./FL | 2.25M | $8.84M | $4.41M | -$4.43M | -50.13% |
| BG Bart Gancher Intech Investment Management LLC | 59,880 | $149,101.2 | $108,682.2 | -$40,419 | -27.11% |
| JM John Malone Amundi | 2.14M | $28.33M | $4.05M | -$24.27M | -85.69% |
Clarivate Plc (CLVT) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Clarivate Plc ever had a stock split?
Clarivate Plc Profile
| Software Industry | Information Technology Sector | Matitiahu Shem Tov CEO | NYSE Exchange | G21810109 CUSIP |
| GB Country | 12,000 Employees | 15 Mar 2018 Last Dividend | - Last Split | 29 Oct 2018 IPO Date |
Overview
Clarivate Plc operates as a distinguished information services provider with a broad geographical footprint spanning the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company offers its services under three main segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. Its mission is to support academic, corporate, and government agencies, along with public libraries and other professional services organizations, with critical data, insights, and services that span the spectrum of academic research, pharmaceutical development, and intellectual property management. Established in 1864 and rebranded from Clarivate Analytics Plc to Clarivate Plc in May 2020, it is headquartered in London, United Kingdom, signifying a legacy combined with a modern approach towards information services.
Products and Services
- Web of Science and InCites: A duo offering that enables the exploration and analysis of the academic research landscape, managing research information effectively.
- ProQuest One and Ebook Central: These platforms provide comprehensive content collections in a cost-effective manner to academic and governmental institutions, enhancing the availability of valuable resources.
- Alma and Polaris: Specialized in managing academic resources and services, these applications facilitate the connection between users and support various research publications through efficient management.
- Patent and Trademark Renewals: Focused on alleviating the workload for paralegals and admins, this service streamlines the process of patent and trademark protection and maintenance.
- CompuMark and Derwent: These services assist in making informed decisions regarding patent and trademark protection, minimizing risk and enhancing value creation through all stages of the innovation and brand lifecycle.
- IPFolio and Foundation IP: Offering a structured environment for the management and protection of global patent and trademark assets, these platforms cater to the nuanced needs of IP management.
- Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence: Support the development of new drugs and medical devices from discovery to clinical trials, providing vital data and insights for the pharmaceutical industry.
- Cortellis Regulatory Intelligence and OFF-X: These tools monitor drug safety issues and ensure adherence to regulatory protocols, vital for the timely and safe development of pharmaceuticals.
- Real World Data and Optimize: Aimed at informing commercial launch strategies and setting pricing for optimal reimbursement, these offerings leverage real-world data to guide healthcare business decisions.
